January 2026
The global monoclonal antibodies market size is evaluated at USD 286.32 billion in 2025 and is projected to hit around USD 880.01 billion by 2035, with a CAGR of 11.88%.
April 2026
The global cancer monoclonal antibodies market size reached USD 125.10 billion in 2025 and is predicted to hit around USD 658.07 billion by 2035, with a solid CAGR of 18.06%.
March 2026
The global veterinary monoclonal antibodies market size is estimated to hit around USD 5.62 billion by 2035 increasing from USD 1.74 billion in 2025, with a CAGR of 12.44%.
July 2026
The global immuno-oncology antibodies market is growing. Learn about market drivers, therapeutic applications, and the companies driving innovation.
June 2026
The global bispecific antibodies market size is valued at USD 17.99 billion in 2025 and is expected to attain around USD 603.13 billion by 2035 at a CAGR of 42.08%.
May 2026
The global biosimilar monoclonal antibody market size is projected to hit around USD 124.43 billion by 2035 from USD 16.01 billion in 2025 with a CAGR of 22.76%.
March 2026
The global bispecific antibodies CDMO market expands with demand for next-generation therapeutics, advanced expression systems, and regulatory compliance expertise.
February 2026
The global research antibodies market size accounted for USD 4.64 billion in 2025 and is projected to hit around USD 7.56 billion by 2035 with a CAGR of 5%.
December 2025
The polyclonal antibodies market size was estimated at USD 1.70 billion in 2025 and is expected to hit around USD 2.95 billion by 2035 with a CAGR of 5.77%.
July 2024
The global recombinant antibodies market size was estimated at USD 12.40 billion in 2023 and is projected to surpass around USD 23.34 billion by 2033 with a CAGR of 6.53%.
July 2025
The global antibody therapy market size reached USD 313.47 billion in 2024 and is predicted to surpass around USD 973.60 billion by 2034, with a solid CAGR of 12%.